How to contact us

For more information please email health.mtrg@lse.ac.uk|

LSE Health
London School of Economics and Political Science
Houghton Street
London
UK
WC2A 2AE

 

Summit programme

Ernst and Young|

 

gold pill

Download the programme| (PDF) 

08.30 – 09.00

Registration and coffee

09.00 - 09.05

Welcome & introduction
Professor David Taylor (chair), University College London

09.05 - 09.30

Keynote

Introduction by David MacMurchy, EY

A European perspective on MEAs
Alessandra Ferrario and Panos Kanavos, London School of Economics and Political Science

Session 1
Lessons from implementing MEAs – Part 1

09.30 - 09.50

Improving rational drug use through monitoring registries
Paolo Siviero, AIFA, Italy

09.50 - 10.10

New developments in the Polish risk-sharing landscape
Jakub Adamski, Polish Ministry of Health

10.10 - 10.30


Progress of the risk sharing scheme in providing MS drugs cost-effectively
Jackie Palace, Oxford University

10.30 - 10.50

Discussion

10.50 - 11.10

Coffee Break

Session 2
Lessons from implementing MEAs - Part 2

11.10 - 11.30

The ability of coverage with evidence development and to address uncertainties and improve performance in drug use
Karl Arnberg, TLV, Sweden

11.30 - 11.50

Results from the first re-assessments of coverage with evidence development schemes (CED): Is CED the way forward to introduce new and high cost medicines?
Caroline van der Meijden, CVZ, the Netherlands

11.50 - 12.10

Discussion

12.10 - 13.10

Lunch

Session 3
Stakeholder perspectives on MEAs

13.10 - 13.30

A manufacturer’s perspective on MEAs and their ability to improve access to medicines
Christophe Carbonel, Novartis

13.30-13.50

Can MEAs help us move towards a value-based pricing model?
Valerie Paris, OECD

13.50-14.10

Discussion

14.10-14.30

Coffee Break

14.30-15.00

Communicating value: The benefits of collaborative negotiation
Charles Barker, PrimeMover Associates LLC

15.00-15.20

Coffee Break

Session 4
The value of collecting additional evidence to improve decision-making – current reflections and future options

15.20 - 16.45

Panel
Chair: Panos Kanavos
Panellists:
Karl Arnberg, TLV, Sweden
Salvatore D’Acunto, EU Commission
Ansgar Hebborn, Roche
Caroline van der Meijden, CVZ, the Netherlands
Jean Mossman, European Brain Council
Silvia Ondategui-Parra, EY
Valerie Paris, OECD
Paolo Siviero, AIFA, Italy
Andrew Stainthorpe, NICE

FT logo16.45 - 17.00

Conclusions and farewell
Panos Kanavos and David Taylor

Share:Facebook|Twitter|LinkedIn|
tablets|
Health Logo|